AI Science Tracker

CONICET–Universidad de Buenos Aires

1 discovery from 2025

Discoveries

Data-centric machine learning prioritizes compounds for Trypanosoma cruzi assays

Ensemble supervised classifiers trained on curated phenotypic activity data prioritized eight repurposing compounds for clinically relevant parasite-stage assays. The article reports six selected compounds with predicted trypanocidal effects, while identifying cytotoxicity as a caveat for two amastigote candidates; mifepristone showed trypomastigote activity. These are in-vitro strain-specific outcomes, not clinical efficacy or novel molecular entities.

Technology: Ensemble molecular-descriptor linear classifiers

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Primary article reports eight in-silico hits and selected-stage experimental confirmation; tables qualify cytotoxicity caveats.
  • Still unknown: Prior compound activity and some full model/supplement details remain for later audit; selected repurposed compounds are not novel molecules.
  • AI role: Data-centric supervised ensembles prioritize repurposing candidates for distinct parasite-stage assays.

Evidence sources: https://doi.org/10.3390/pharmaceutics17121513

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: publisher primary full text and tables. Material checked for the specific claims stated in the record..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.